Misty D. Bear

1.0k total citations
28 papers, 805 citations indexed

About

Misty D. Bear is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Misty D. Bear has authored 28 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in Misty D. Bear's work include Virus-based gene therapy research (10 papers), Veterinary Oncology Research (7 papers) and Cancer Research and Treatments (6 papers). Misty D. Bear is often cited by papers focused on Virus-based gene therapy research (10 papers), Veterinary Oncology Research (7 papers) and Cancer Research and Treatments (6 papers). Misty D. Bear collaborates with scholars based in United States, Hong Kong and Denmark. Misty D. Bear's co-authors include Cheryl A. London, William C. Kisseberth, Stacey Fossey, Michael L. Pennell, Kevin P. Foley, Weiwen Ying, James Barsoum, Tzu‐yin Lin, Joelle M. Fenger and Jiayuh Lin and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Misty D. Bear

26 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misty D. Bear United States 15 473 255 227 156 138 28 805
Joana Cabral Portugal 13 526 1.1× 139 0.5× 141 0.6× 93 0.6× 323 2.3× 15 825
Sandra Carvalho Portugal 17 687 1.5× 227 0.9× 173 0.8× 81 0.5× 376 2.7× 21 1.2k
Norishige Yamada Japan 21 754 1.6× 363 1.4× 96 0.4× 66 0.4× 153 1.1× 30 1.1k
Samuel J. Vidal United States 7 473 1.0× 308 1.2× 164 0.7× 30 0.2× 73 0.5× 12 798
Sangeeta Bafna United States 10 636 1.3× 290 1.1× 127 0.6× 36 0.2× 206 1.5× 12 896
Bharvin K.R. Patel United States 17 623 1.3× 560 2.2× 78 0.3× 86 0.6× 259 1.9× 29 1.1k
Tuhina Mazumdar United States 17 398 0.8× 232 0.9× 104 0.5× 28 0.2× 143 1.0× 32 785
С. В. Вторушин Russia 15 298 0.6× 388 1.5× 108 0.5× 44 0.3× 105 0.8× 78 841
Robert A. Olie Switzerland 16 1.1k 2.3× 361 1.4× 94 0.4× 91 0.6× 153 1.1× 26 1.3k
Huihua Zhang China 14 322 0.7× 363 1.4× 105 0.5× 40 0.3× 151 1.1× 38 757

Countries citing papers authored by Misty D. Bear

Since Specialization
Citations

This map shows the geographic impact of Misty D. Bear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misty D. Bear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misty D. Bear more than expected).

Fields of papers citing papers by Misty D. Bear

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misty D. Bear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misty D. Bear. The network helps show where Misty D. Bear may publish in the future.

Co-authorship network of co-authors of Misty D. Bear

This figure shows the co-authorship network connecting the top 25 collaborators of Misty D. Bear. A scholar is included among the top collaborators of Misty D. Bear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misty D. Bear. Misty D. Bear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kleinhenz, Michael D., Andrew Curtis, Abbie V. Viscardi, et al.. (2025). Comparison of multiple drug regimens for reduction of synovitis-induced lameness pain in meat-type goats. American Journal of Veterinary Research. 86(10).
2.
Bear, Misty D., Daniel A. Morgenstern, Karsten Nysom, et al.. (2022). 891P Naxitamab treatment for relapsed or refractory high-risk neuroblastoma: Outcomes from the first prespecified analyses of the Pivotal 201 Trial. Annals of Oncology. 33. S956–S956. 6 indexed citations
3.
4.
London, Cheryl A., Jaime Acquaviva, Donald L. Smith, et al.. (2018). Consecutive Day HSP90 Inhibitor Administration Improves Efficacy in Murine Models of KIT-Driven Malignancies and Canine Mast Cell Tumors. Clinical Cancer Research. 24(24). 6396–6407. 8 indexed citations
5.
Gardner, Heather L., Misty D. Bear, Kim Cronin, et al.. (2018). Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma. PLoS ONE. 13(4). e0195357–e0195357. 13 indexed citations
6.
Fenger, Joelle M., Ryan D. Roberts, O. Hans Iwenofu, et al.. (2016). MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines. BMC Cancer. 16(1). 784–784. 33 indexed citations
7.
London, Cheryl A., et al.. (2015). Abstract 4700: The novel and selective PI3Kδ inhibitor, RV1001, displays single agent biologic activity in spontaneous canine NHL. Cancer Research. 75(15_Supplement). 4700–4700. 2 indexed citations
8.
Bear, Misty D., et al.. (2015). Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma. BMC Veterinary Research. 11(1). 206–206. 29 indexed citations
9.
Fenger, Joelle M., Misty D. Bear, Stefano Volinia, et al.. (2014). Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer. 14(1). 84–84. 32 indexed citations
10.
Kisseberth, William C., Misty D. Bear, Yosef Landesman, et al.. (2014). Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines. BMC Veterinary Research. 10(1). 160–160. 20 indexed citations
11.
London, Cheryl A., William C. Kisseberth, Antonella Borgatti, et al.. (2014). Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study. PLoS ONE. 9(2). e87585–e87585. 79 indexed citations
12.
Bear, Misty D., et al.. (2012). Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines. BMC Veterinary Research. 8(1). 244–244. 18 indexed citations
13.
Fossey, Stacey, Misty D. Bear, William C. Kisseberth, Michael L. Pennell, & Cheryl A. London. (2011). Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines. BMC Cancer. 11(1). 125–125. 92 indexed citations
14.
Fossey, Stacey, Misty D. Bear, Jiayuh Lin, et al.. (2011). The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer. 11(1). 112–112. 79 indexed citations
15.
London, Cheryl A., Misty D. Bear, Kevin P. Foley, et al.. (2011). Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer. PLoS ONE. 6(11). e27018–e27018. 32 indexed citations
16.
Bear, Misty D., et al.. (2010). Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro. American Journal of Veterinary Research. 71(7). 799–808. 16 indexed citations
17.
Bear, Misty D., Stacey Fossey, Robert Mihalek, et al.. (2009). The novel HSP90 inhibitor STA‐1474 exhibits biologic activity against osteosarcoma cell lines. International Journal of Cancer. 125(12). 2792–2801. 62 indexed citations
18.
Fossey, Stacey, Albert Taiching Liao, Misty D. Bear, et al.. (2009). Characterization of STAT3 activation and expression in canine and human osteosarcoma. BMC Cancer. 9(1). 81–81. 93 indexed citations
19.
Bear, Misty D., et al.. (2008). The novel HSP90 inhibitor STA-9090 exhibits activity against Kit dependent and independent malignant mast cell tumors.. Cancer Research. 68. 5638–5638. 2 indexed citations
20.
Lin, Tzu‐yin, Misty D. Bear, Zhenjian Du, et al.. (2008). The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Experimental Hematology. 36(10). 1266–1277. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joana Cabral Breakdown of academic impact, for papers by Sandra Carvalho Breakdown of academic impact, for papers by Norishige Yamada Breakdown of academic impact, for papers by Samuel J. Vidal Breakdown of academic impact, for papers by Sangeeta Bafna Breakdown of academic impact, for papers by Bharvin K.R. Patel Breakdown of academic impact, for papers by Tuhina Mazumdar Breakdown of academic impact, for papers by С. В. Вторушин Breakdown of academic impact, for papers by Robert A. Olie Breakdown of academic impact, for papers by Huihua Zhang
Rankless by CCL
2026